Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2014; 20(24): 7819-7829
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7819
Figure 1
Figure 1 Multiple randomized phase III trials have been completed in the last decades; however, we have not been able to cross the barrier of 12 mo survival in advanced pancreatic cancer.